MBX 4291 — Topline data
Q4 2026
MBX 4291 12-week Phase 1 MAD Part C data remain on track for Q4 2026Source filing
MBX biotech catalysts & pipeline
MBX BIOSCIENCES INC · Data as of 2026-09-08
Upcoming catalysts
MBX 6180 — Conference presentation
Q4 2026
We expect to present preclinical data from MBX 6180 at a scientific meeting in the fourth quarter of 2026.Source filing